Market Size of Proteomics Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 27.60 Billion |
| Market Size (2029) | USD 41.36 Billion |
| CAGR (2024 - 2029) | 8.42 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Proteomics Market Analysis
The Proteomics Market size is estimated at USD 27.60 billion in 2024, and is expected to reach USD 41.36 billion by 2029, growing at a CAGR of 8.42% during the forecast period (2024-2029).
Certain factors driving the market growth include rising demand for personalized medicine, increasing R&D expenditure and government funding for proteomics, and technological advancements.
These major drivers will continue to drive the biopharmaceutical industry's pursuit of blockbuster drugs and the recent technological advances in the studies of genes and proteins. Alliances are becoming increasingly important in this field because it is challenging for companies to find all the necessary expertise to cover all activities involved in proteomics. For example, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies. Increased demand for personalized medicines and increased R&D in proteomics are also driving factors for the market. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
Proteomics Industry Segmentation
Proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.
| By Product & Services | ||||||||
| ||||||||
| Reagents | ||||||||
| Software and Services |
| By Application | |
| Clinical Diagnostics | |
| Drug Discovery | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Proteomics Market Size Summary
The proteomics market is poised for significant growth, driven by the increasing demand for personalized medicine and advancements in research and development. The biopharmaceutical industry is particularly focused on developing blockbuster drugs, leveraging recent technological advancements in gene and protein studies. Collaborations are becoming essential as companies seek to integrate diverse expertise across proteomics activities, such as mass spectrometry and protein chip technologies. Despite the promising developments in drug discovery, which rely on genome and proteome information to identify disease-associated proteins, the market faces challenges from stringent regulatory norms and the high costs of proteomics instruments. The pharmaceutical sector is increasingly incorporating proteomics into drug development, utilizing it for biomarker identification, target validation, and understanding drug mechanisms.
In North America, the proteomics market is vibrant, with antibody-drug conjugates and protein therapeutics playing a crucial role in disease treatment and diagnosis. The region is at the forefront of research, particularly in the United States, where extensive studies on next-generation therapeutics are underway. The global market is highly competitive, with major players like Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific holding substantial market shares. These companies are actively expanding their offerings, as seen with Agilent's launch of a SARS-CoV-2 detection kit and Thermo Fisher's acquisition of Phitonex to enhance protein and cell analysis capabilities.
Proteomics Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Demand for Personalized Medicine
-
1.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
-
1.2.3 Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Instruments
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product & Services
-
2.1.1 Instrumentation Technology
-
2.1.1.1 Spectroscopy
-
2.1.1.2 Chromatography
-
2.1.1.3 Electrophoresis
-
2.1.1.4 Protein Microarrays
-
2.1.1.5 X-Ray Crystallography
-
2.1.1.6 Other Instrumentation Technologies
-
-
2.1.2 Reagents
-
2.1.3 Software and Services
-
-
2.2 By Application
-
2.2.1 Clinical Diagnostics
-
2.2.2 Drug Discovery
-
2.2.3 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East & Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East & Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Proteomics Market Size FAQs
How big is the Proteomics Market?
The Proteomics Market size is expected to reach USD 27.60 billion in 2024 and grow at a CAGR of 8.42% to reach USD 41.36 billion by 2029.
What is the current Proteomics Market size?
In 2024, the Proteomics Market size is expected to reach USD 27.60 billion.
